Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease
Authors
Keywords
-
Journal
NATURE
Volume 543, Issue 7643, Pages 108-112
Publisher
Springer Nature
Online
2017-02-21
DOI
10.1038/nature21368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
- (2016) Shiny Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
- (2016) G. Arbore et al. SCIENCE
- Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages
- (2015) Elma Aflaki et al. AGING CELL
- The Influence of Genetic Variability and Proinflammatory Status on the Development of Bone Disease in Patients with Gaucher Disease
- (2015) Javier Gervas-Arruga et al. PLoS One
- Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease
- (2014) Laura van Dussen et al. Orphanet Journal of Rare Diseases
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model
- (2013) Manoj Kumar Pandey et al. MOLECULAR GENETICS AND METABOLISM
- Microarray expression analysis and identification of serum biomarkers for Niemann–Pick disease, type C1
- (2012) Celine V.M. Cluzeau et al. HUMAN MOLECULAR GENETICS
- Immunological cell type characterization and Th1–Th17 cytokine production in a mouse model of Gaucher disease
- (2012) Manoj Kumar Pandey et al. MOLECULAR GENETICS AND METABOLISM
- Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
- (2010) Y. Sun et al. HUMAN MOLECULAR GENETICS
- The risk of Parkinson’s disease in type 1 Gaucher disease
- (2010) Gilberto Bultron et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Both FcγRIV and FcγRIII are essential receptors mediating type II and type III autoimmune responsesviaFcRγ-LAT-dependent generation of C5a
- (2009) Shahzad N. Syed et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells
- (2009) Donald J. Weaver et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells
- (2008) Michael G. Strainic et al. IMMUNITY
- Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid β-glucosidase residual activity levels
- (2008) You-Hai Xu et al. MOLECULAR GENETICS AND METABOLISM
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now